List of Studies ( Metabolite:Tegaserod)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | Absolute Intensity |
| ST002758 | AN004477 | Metabolic responses of normal rat kidneys to a high salt intake (Plasma) | Blood | Rat | Medical College of Wisconsin | Area | |
| ST002760 | AN004485 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST003333 | AN005460 | Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study | Urine | Human | Environmental exposure; Hypoxia | Defence Institute of Physiology and Allied Sceinces | Peak area |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
